Bionomics Limited Stock Short Ratio
BNOEFDelisted Stock | USD 0.01 0.00 0.00% |
Bionomics Limited fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Pink Sheet. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics pink sheet.
Bionomics |
Bionomics Limited Company Short Ratio Analysis
Bionomics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Bionomics Limited has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
All Next | Launch Module |
Bionomics Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.18 | |||
Operating Margin | (2.91) % | |||
Current Valuation | 27.83 M | |||
Shares Outstanding | 1.35 B | |||
Shares Owned By Insiders | 6.00 % | |||
Shares Owned By Institutions | 48.96 % | |||
Price To Earning | (34.09) X | |||
Price To Book | 1.24 X | |||
Price To Sales | 8.29 X | |||
Revenue | 263.63 K | |||
Gross Profit | (9.94 M) | |||
EBITDA | (21.92 M) | |||
Net Income | (21.76 M) | |||
Cash And Equivalents | 33.56 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 693.62 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 12.46 X | |||
Book Value Per Share | 0.04 X | |||
Cash Flow From Operations | (21.76 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 22 | |||
Beta | 2.18 | |||
Market Capitalization | 29.11 M | |||
Total Asset | 65.31 M | |||
Retained Earnings | (103 M) | |||
Working Capital | 47 M | |||
Current Asset | 58 M | |||
Current Liabilities | 11 M | |||
Z Score | 23.2 | |||
Net Asset | 65.31 M |
About Bionomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bionomics Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |